Dosage forms that we support:
Oral solid dosage forms and oral liquids
including API or formulated API in a bottle or capsule, immediate release tablets, orally disintegrating tablets, solutions and suspensions
Parenteral dosage forms for infusion and injection
including IV, IM and SC formats
Radiolabelled drug products
including powder/API in capsule; oral suspension solution; parenteral; amorphous dispersion (drug product intermediates); and powder/API in bottle for extemporaneous preparation at the clinical unit.
Solubility-enhanced dosage forms
including complexes in a bottle, capsule, or tablet format; lipidic vehicles; micronized API in a bottle, capsule, or tablet format; and amorphous dispersion in a bottle, capsule, or tablet format.